Overview

• THG has sold Claremont Ingredients, its in-house flavor lab, to Nactarome Group for £103m.
• The transaction secures a long-term supply contract to maintain flavor development for Myprotein.
• Sale proceeds will go towards reducing the group’s net leverage and lowering borrowing costs.
• Record-high whey prices drove half-year EBITDA down from £37.1m to £24m and prompted earnings forecast cuts of £5m for 2025 and £10m for 2026.
• CEO Matthew Moulding publicly renewed accusations that investment bank Numis circulated false rumors to destabilize THG.